Sequential hypofractionated versus concurrent twice-daily radiotherapy for limited-stage small-cell lung cancer: a propensity score-matched analysis

HIGHLIGHTS

• who: Wei Zhou and collaborators from the Department of Radiation Oncology, Xijing Hospital, Air Force Medical University, Xi'an, China have published the Article: Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis, in the Journal: Cancers 2022, 14, 3920. https:// of 10/08/2022
• what: The authors evaluated survival, toxicities, and failure patterns between a concurrent twice-daily schedule with sequential hypofractionated radiotherapy (sequential hypo) in LS-SCLC by PSM analysis.
• how: In a retrospective study hypoTRT and conventional once-daily TRT . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.